{"id":52296,"date":"2020-05-20T11:37:18","date_gmt":"2020-05-20T15:37:18","guid":{"rendered":"https:\/\/asweetlife.org\/?p=52296"},"modified":"2020-05-20T11:39:05","modified_gmt":"2020-05-20T15:39:05","slug":"first-data-on-type-1-diabetes-deaths-due-to-covid-19","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=52296","title":{"rendered":"First Data on Type 1 Diabetes Deaths Due to COVID-19"},"content":{"rendered":"

People with Type 1 diabetes are roughly 3 times as likely to die of COVID-19 as the nondiabetic population, and are at a higher risk than those with Type 2 diabetes, according to a new study.<\/p>\n

The study<\/a>\u00a0is the first we are aware of that explicitly analyzes the outcomes of people with Type 1 diabetes in the coronavirus pandemic. That people with Type 1 diabetes have such an increased rate of death is just one of several noteable conclusions. Poor blood sugar control and obesity were also found to contribute significantly to the risk of death. Advanced age, however, remains the single most important factor in severe COVID-19 outcomes.<\/p>\n

The work, which comes from the UK and is funded by the National Health Service, actually has two linked papers: one<\/a> in which mortality rates are analyzed in comparison to recent pre-pandemic levels, and another<\/a> in which in-hospital COVID-19 deaths are scrutinized in particular. Outcomes of Type 2 diabetes were also addressed in detail (and will be discussed in a later article).<\/p>\n

\"COVID-19<\/p>\n

 <\/p>\n

The graphic above shows the increase in rate of death, the degree to which it outpaces Type 2 and nondiabetic mortality rates, and how profoundly the risk of death is tied to age.<\/p>\n

Researchers found that the rate of death in people with Type 1 diabetes in England was 148% higher than usual since the start of the pandemic. For reference<\/a>, from March onwards death from all causes in England and Wales has increased by about 50%, which suggests that the risk of death for people diabetes is about three times as high as for people without, superficially confirming the conclusions of the researchers.<\/p>\n

The study authors probed many different factors to draw conclusions that could help patients and doctors improve these outcomes.<\/p>\n

One of the study authors, Partha Kar, gives a good quick summary of the study and its biggest takeaways in this Tweeted video:<\/p>\n

 <\/p>\n

\n

A short sharp video regards data related to #Diabetes<\/a> & #COVID19<\/a> @NHSDiabetesProg<\/a> @NHSEngland<\/a> @DiabetesUK<\/a> @JDRFUK<\/a> @DSNforumUK<\/a> @_diabetes101<\/a> @NHSGIRFT<\/a> pic.twitter.com\/HxWxcjeJaf<\/a><\/p>\n

— Partha S Kar ?????? (@parthaskar) May 20, 2020<\/a><\/p><\/blockquote>\n